Hospital
Lifemark Hospitals of Florida, INC.
Lifemark Hospitals of Florida, INC. was paid $7.11M by Medicaid between Jan 2018 and Sep 2021, across 208 billing codes. Its largest line is U0002, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc — 8.2% of everything it billed.
33Billing provider infoLIFEMARK HOSPITALS OF FLORIDA, INC.
HIALEAH, FL 33016
HIALEAH, FL 33016
33aNPI1568493641assigned 07/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.11M
24GClaims423,629
24DCodes billed208
24AFirst – last monthJan 2018 – Sep 2021
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#70 of 163
Median peer was paid$4.77M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 67,222 | $1.50M | |
| 2019 | 190,189 | $2.80M | |
| 2020 | 96,099 | $1.70M | |
| 2021 | 70,119 | $1.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 8.2% | 5,734 | 4,920 | $579K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.8% | 17,409 | 15,879 | $551K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 7.6% | 3,031 | 2,565 | $540K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.6% | 5,916 | 4,536 | $326K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.5% | 13,427 | 11,908 | $322K |
| 36415 | Collection of venous blood by venipuncture | 4.1% | 9,081 | 5,543 | $291K |
| 80053 | Comprehensive metabolic panel | 3.4% | 11,344 | 8,622 | $243K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.3% | 3,740 | 739 | $233K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 4,126 | 3,406 | $195K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.6% | 3,295 | 2,983 | $186K |
| S0028 | Injection, famotidine, 20 mg | 2.5% | 2,484 | 2,086 | $181K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.5% | 1,158 | 345 | $176K |
196 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 7,561 | $170K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.2% | 11,386 | $154K |
| 99285 | Emergency room visit (most serious) | 2.1% | 7,889 | $146K |
| J3490 | Unclassified drugs | 1.9% | 695 | $135K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.9% | 3,235 | $132K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 1,171 | $108K |
| 81001 | 1.4% | 8,556 | $103K | |
| 87400 | 1.3% | 5,271 | $91K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.2% | 2,202 | $83K |
| 87070 | 1.2% | 3,393 | $82K | |
| 82962 | 1.1% | 6,454 | $80K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.1% | 924 | $79K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 2,839 | $76K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 23,247 | $75K |
| G0378 | Hospital observation service, per hour | <1% | 9,694 | $69K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,235 | $58K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,079 | $56K |
| 71045 | Radiologic examination, chest; single view | <1% | 9,653 | $53K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,538 | $52K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,266 | $51K |
| 81003 | <1% | 3,735 | $48K | |
| 84484 | <1% | 9,842 | $43K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 721 | $42K |
| 81025 | <1% | 3,110 | $41K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 1,261 | $41K |
| 96376 | <1% | 2,348 | $35K | |
| A9270 | Non-covered item or service | <1% | 4,760 | $33K |
| 83735 | <1% | 3,330 | $33K | |
| 76830 | Ultrasound, transvaginal | <1% | 811 | $33K |
| 85610 | <1% | 12,744 | $32K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,763 | $31K |
| 84100 | <1% | 2,161 | $31K | |
| 85730 | <1% | 12,305 | $31K | |
| 86850 | <1% | 3,654 | $31K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,623 | $31K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 921 | $27K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 850 | $26K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,330 | $26K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 969 | $25K |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 2,287 | $25K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,237 | $25K |
| 87040 | <1% | 4,043 | $25K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,342 | $25K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 249 | $23K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,731 | $22K |
| 82805 | <1% | 982 | $22K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 607 | $21K |
| 74018 | <1% | 786 | $20K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 154 | $20K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,180 | $20K |
| 76818 | <1% | 354 | $19K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,425 | $19K |
| 83880 | <1% | 2,373 | $16K | |
| 82550 | <1% | 5,553 | $16K | |
| 59025 | Fetal non-stress test | <1% | 457 | $16K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 897 | $15K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,929 | $14K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,251 | $14K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,258 | $13K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,213 | $13K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,354 | $13K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 983 | $12K |
| 86900 | <1% | 3,721 | $12K | |
| 86901 | <1% | 3,731 | $11K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,796 | $10K |
| 73610 | <1% | 379 | $10K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,302 | $10K |
| 97161 | <1% | 771 | $10K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 275 | $10K |
| 80076 | <1% | 3,750 | $9K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 564 | $9K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 108 | $9K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,430 | $9K |
| 73562 | <1% | 446 | $9K | |
| J1815 | Injection, insulin, per 5 units | <1% | 680 | $9K |
| 80061 | Lipid panel | <1% | 2,412 | $9K |
| 76801 | <1% | 810 | $9K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,636 | $8K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 894 | $8K |
| 84702 | <1% | 2,646 | $8K | |
| 83690 | <1% | 4,533 | $8K | |
| 73630 | <1% | 485 | $8K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 209 | $8K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 746 | $8K |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 235 | $6K |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 172 | $6K |
| 87088 | <1% | 4,554 | $6K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 205 | $6K |
| 93971 | <1% | 336 | $6K | |
| 73030 | <1% | 394 | $5K | |
| 83605 | <1% | 2,069 | $5K | |
| 72100 | <1% | 637 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,586 | $4K |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 1,407 | $4K |
| 74019 | <1% | 135 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 748 | $4K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,805 | $4K |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 74 | $4K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 579 | $4K |
| 82607 | <1% | 686 | $4K | |
| 82150 | <1% | 1,553 | $4K | |
| 93970 | <1% | 374 | $4K | |
| 87077 | <1% | 1,581 | $4K | |
| 87045 | <1% | 78 | $4K | |
| A4217 | Sterile water/saline, 500 ml | <1% | 541 | $3K |
| 73110 | <1% | 118 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 833 | $3K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 839 | $3K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 249 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,525 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,350 | $3K |
| 76641 | <1% | 162 | $3K | |
| 71250 | <1% | 413 | $3K | |
| 73130 | <1% | 117 | $2K | |
| 84703 | <1% | 3,207 | $2K | |
| 87205 | <1% | 761 | $2K | |
| 29125 | <1% | 58 | $2K | |
| C1769 | Guide wire | <1% | 322 | $2K |
| 97162 | <1% | 66 | $2K | |
| 87186 | <1% | 1,438 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 798 | $2K |
| 96367 | <1% | 207 | $2K | |
| 87420 | <1% | 522 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 597 | $2K |
| 72170 | <1% | 339 | $2K | |
| 83540 | <1% | 381 | $2K | |
| 12011 | <1% | 50 | $2K | |
| 70486 | <1% | 192 | $1K | |
| 82728 | <1% | 498 | $1K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 264 | $1K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 876 | $1K |
| 82746 | <1% | 450 | $1K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,121 | $967.56 |
| 72040 | <1% | 19 | $940.25 | |
| 85379 | <1% | 910 | $916.52 | |
| 82731 | <1% | 13 | $886.79 | |
| 84112 | <1% | 14 | $753.94 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 59 | $736.70 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 65 | $644.17 |
| 93880 | <1% | 89 | $591.94 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,345 | $590.54 |
| 77080 | <1% | 119 | $587.17 | |
| 93976 | <1% | 27 | $565.26 | |
| 73080 | <1% | 34 | $551.32 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 66 | $538.58 |
| 85045 | <1% | 59 | $538.58 | |
| 84439 | <1% | 274 | $519.91 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 331 | $424.45 |
| 92523 | <1% | 13 | $422.68 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 101 | $414.89 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 755 | $399.68 |
| 73590 | <1% | 49 | $394.93 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 80 | $376.43 |
| 76770 | <1% | 31 | $350.84 | |
| 77066 | Tomosynthesis, mammo | <1% | 24 | $349.27 |
| 84132 | <1% | 59 | $343.48 | |
| 84550 | <1% | 300 | $307.43 | |
| 73502 | <1% | 65 | $307.27 | |
| 90714 | <1% | 105 | $211.12 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 105 | $202.48 |
| 12002 | <1% | 16 | $194.04 | |
| 86403 | <1% | 18 | $170.64 | |
| 88304 | <1% | 46 | $118.72 | |
| 86141 | <1% | 596 | $104.47 | |
| 82248 | <1% | 195 | $87.02 | |
| 86738 | <1% | 97 | $65.36 | |
| 84145 | <1% | 141 | $25.21 | |
| 88313 | <1% | 12 | $18.66 | |
| 86140 | <1% | 499 | $13.22 | |
| 83550 | <1% | 131 | $8.09 | |
| 83615 | <1% | 179 | $5.90 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 116 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 144 | $0.00 |
| J1741 | Injection, ibuprofen, 100 mg | 0% | 18 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 34 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 44 | $0.00 |
| 88342 | 0% | 41 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 315 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 56 | $0.00 |
| 85651 | 0% | 40 | $0.00 | |
| 88300 | 0% | 37 | $0.00 | |
| J0456 | Injection, azithromycin, 500 mg | 0% | 13 | $0.00 |
| 87081 | 0% | 16 | $0.00 | |
| 86592 | 0% | 30 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 15 | $0.00 |
| 99001 | 0% | 1,105 | $0.00 | |
| 99218 | 0% | 127 | $0.00 | |
| 85384 | 0% | 236 | $0.00 | |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 221 | $0.00 |
| 87185 | 0% | 27 | $0.00 | |
| 00840 | 0% | 15 | $0.00 | |
| 82140 | 0% | 23 | $0.00 | |
| 87899 | 0% | 115 | $0.00 | |
| 85007 | 0% | 13 | $0.00 | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 0% | 26 | $0.00 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARMIN, CRAIG (VP GOVT PROGRAMS, TENET HEALTHCARE)
| Provider | Location | Paid |
|---|---|---|
| North Shore Medical Center, INC. | Miami, FL | $4.42M |
| Hialeah Hospital INC. | Hialeah, FL | $3.62M |
| North Shore Medical Center, INC. | Lauderdale Lakes, FL | $2.52M |
| CGH Hospital, LTD. | Coral Gables, FL | $1.67M |
| VHS West Suburban Medical Center INC | Oak Park, IL | $1.46M |
| VHS Westlake Hospital INC | Melrose Park, IL | $326K |
| Tenet Healthsystem ST. Christopher's Hospital for Children, LLC | Philadelphia, PA | $22K |
| FMC Hospital, LTD. | Lauderdale Lakes, FL | $4K |
| San Dimas Community Hospital, INC. | San Dimas, CA | $963.01 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.